{
    "id": 10243,
    "fullName": "BAP1 inact mut",
    "impact": "unknown",
    "proteinEffect": "loss of function",
    "geneVariantDescriptions": [
        {
            "description": "BAP1 inact mut indicates that this variant results in a loss of function of the Bap1 protein. However, the specific amino acid change has not been identified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 8314,
        "geneSymbol": "BAP1",
        "terms": [
            "BAP1",
            "HUCEP-13",
            "hucep-6",
            "UCHL2"
        ]
    },
    "variant": "inact mut",
    "createDate": "08/06/2015",
    "updateDate": "08/06/2015",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9955,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, renal clear cell carcinoma cells harboring BAP1 inactivating mutations demonstrated increased sensitivity to Lynparza (olaparib) in culture (PMID: 22683710).",
            "molecularProfile": {
                "id": 10246,
                "profileName": "BAP1 inact mut"
            },
            "therapy": {
                "id": 837,
                "therapyName": "Olaparib",
                "synonyms": null
            },
            "indication": {
                "id": 4467,
                "name": "clear cell renal cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 3409,
                    "pubMedId": 22683710,
                    "title": "BAP1 loss defines a new class of renal cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22683710"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 10246,
            "profileName": "BAP1 inact mut",
            "profileTreatmentApproaches": [
                {
                    "id": 6368,
                    "name": "PARP Inhibitor (Pan)",
                    "profileName": "BAP1 inact mut"
                },
                {
                    "id": 6367,
                    "name": "HDAC Inhibitor",
                    "profileName": "BAP1 inact mut"
                },
                {
                    "id": 6369,
                    "name": "PARP-1 Inhibitor",
                    "profileName": "BAP1 inact mut"
                },
                {
                    "id": 6370,
                    "name": "PARP-2 Inhibitor",
                    "profileName": "BAP1 inact mut"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}